HEMATIM - Hématopoïese et immunologie

Type: Research entity evaluation report

Evaluation campaign: 2024-2025 (group E) - Published on: 18/03/2025

Institution(s) concerned: Université de Picardie Jules Verne - UPJV

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE3 Microbiology, Virology, Immunity

ERC panel(s): LS Life Sciences ; LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction ; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals ; LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS6 Immunity and infection: immunobiology, aetiology of immune disorders, microbiology, virology, parasitology, global and other infectious diseases, population dynamics of infectious diseases, veterinary medicine

Keywords: Thérapies cellulaires et cancer;